Abstract
DOPAMINE receptors belong to a large class of neurotransmitter and hormone receptors that are linked to their signal transduction pathways through guanine nucleotide binding regulatory proteins (G proteins). Pharmacological, biochemical and physiological criteria have been used to define two subcategories of dopamine receptors1 referred to as D1 and D2. D1 receptors activate adenylyl cyclase2 and are coupled with the Gs regulatory protein3. By contrast, activation of D2 receptors results in various responses including inhibition of adenylyl cyclase4, inhibition of phosphatidylinositol turnover5, increase in K+ channel activity6 and inhibition of Ca2+ mobilization7. The G protein(s) linking the D2 receptors to these responses have not been identified, although D2 receptors have been shown to both copurify8,9 and functionally reconstitute10,11 with both Gi and Go related proteins3. The diversity of responses elicited by D2-receptor activation could reflect the existence of multiple D2 receptor subtypes, the identification of which is facilitated by the recent cloning of a complementary DNA encoding a rat D2 receptor12. This receptor exhibits considerable amino-acid homology with other members of the G protein-coupled receptor superfamily12,13. Here we report the identification and cloning of a cDNA encoding an RNA splice variant of the rat D2 receptor cDNA12. This cDNA codes for a receptor isoform which is predominantly expressed in the brain, and contains an additional 29 amino acids in the third cytoplasmic loop, a region believed to be involved in G protein coupling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Eds, Creese, I. & Fraser, C. M. Receptor Biochemistry and Methodology: Dopamine Receptors 8, (Liss, New York, 1987).
Kebabian, J. W. et al. Trends Pharmacol. 7, 96–99 (1986).
Freissmuth, M., Casey, P. J. & Gilman, A. G. FASEB J. 3, 2125–2132 (1989).
Creese, I., Sibley, D. R., Hamblin, M. W. & Leff, S. E. A. Rev. Neurosci. 6, 43–71 (1983).
Vallar, L. & Meldolesi, J. Trends Pharmacol. 10, 74–77 (1989).
Lacey, M. G., Mercuri, N. B. & North, R. A. J. Physiol. 392, 397–416 (1987).
Bigornia, L. et al. J. Neurochem. 51, 999–1006 (1988).
Senogles, S. E. et al. J. biol. Chem. 262, 4860–4867 (1987).
Elazar, Z., Siegel, G. & Fuchs, S. EMBO J. 8, 2353–2357 (1989).
Senogles, S. E., Amlaiky, N., Falardeau, P. & Caron, M. G. J. biol. Chem. 263, 18996–19002 (1988).
Ohara, K. et al. Molec. Pharm. 33, 290–296 (1988).
Bunzow, J. R. et al. Nature 336, 783–787 (1988).
O'Dowd, B. F., Lefkowitz, R. J. & Caron, M. G. A. Rev. Neurosci. 12, 67–83 (1989).
Mount, S. M. Nucleic Acids. Res. 10, 459–472 (1982).
Templton, D. & Eckhart, W. J. molec. Cell Biol. 4, 817–821 (1984).
Chen, C. & Okayama, H., J. molec. Cell Biol. 7, 2745–2752 (1987).
Monsma, F. J., Jr., Brassard, D. L. & Sibley, D. R. Brain Res. 492, 214–324 (1989).
Sibley, D. R., De Lean, A. & Creese, I. J. biol. Chem. 257, 6351–6361 (1982).
Andreadis, A., Gallego, M. E., Nadal-Ginard, B. A. Rev. Cell Biol. 3, 207–242 (1987).
Strader, C. D., Sigal, I. S. & Dixon, R. A. F. FASEB J. 3, 1825–1832 (1989).
O'Dowd, B. F. et al. J. biol. Chem. 263, 15985–15992 (1988).
Okayama, H. et al. Meth. Enzym. 154, 3–28 (1987).
Gerfen, C. R. & Young, W. S. Brain Res. 460, 161–167 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Monsma, F., McVittie, L., Gerfen, C. et al. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342, 926–929 (1989). https://doi.org/10.1038/342926a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/342926a0
This article is cited by
-
The human neuropsychiatric risk gene Drd2 is necessary for social functioning across evolutionary distant species
Molecular Psychiatry (2023)
-
The dopaminergic control of Cushing’s syndrome
Journal of Endocrinological Investigation (2022)
-
New Antipsychotic Medications in the Last Decade
Current Psychiatry Reports (2021)
-
Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain
Brain Structure and Function (2019)
-
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Nature (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.